EMEA-001308-PIP01-12-M02
Key facts
Invented name |
Abraxane
|
Active substance |
paclitaxel
|
Therapeutic area |
Oncology
|
Decision number |
P/0257/2018
|
PIP number |
EMEA-001308-PIP01-12-M02
|
Pharmaceutical form(s) |
Powder for suspension for infusion
|
Condition(s) / indication(s) |
Treatment of solid malignant tumours
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Celgene Europe Limited
Tel. +41 327298500 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001308-PIP01-12-M02
|
Compliance opinion date |
21/09/2018
|
Compliance outcome |
positive
|